Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial-Reference-Cited by-同舟云学术

Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial

Published:2008-05-13 Issue:20 Volume:29 Page:2473-2479
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:European Heart Journal

Author:

Murphy S. A.,Antman E. M.,Wiviott S. D.,Weerakkody G.,Morocutti G.,Huber K.,Lopez-Sendon J.,McCabe C. H.,Braunwald E.,

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/29/20/2473/1234151/ehn362.pdf

Reference18 articles.

1. Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

2. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38)

3. Challenges and Opportunities in Quantifying the Quality of Care for Acute Myocardial Infarction

4. The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI

5. Predictors of Outcome in Patients With Acute Coronary Syndromes Without Persistent ST-Segment Elevation

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Bempedoic Acid on Total Cardiovascular Events;JAMA Cardiology;2024-03-01

2. Total events and net clinical benefit of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: The COMPASS trial;American Heart Journal;2023-04

3. The effect of a Prasugrel- vs. a Ticagrelor-based strategy on total ischaemic and bleeding events in patients with acute coronary syndromes;European Heart Journal - Cardiovascular Pharmacotherapy;2022-11-26

4. EFFECTIVENESS AND SAFETY COMPARISON OF P2Y12 RECEPTOR INHIBITORS IN PATIENTS WITH INVASIVE STRATEGY FOR ACUTE CORONARY SYNDROME;Tavricheskiy Mediko-Biologicheskiy Vestnik;2022-10-19

5. Total Cardiovascular and Limb Events and the Impact of Polyvascular Disease in Chronic Symptomatic Peripheral Artery Disease;Journal of the American Heart Association;2022-06-07